Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniele Remotti

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Anti-Cancer Drugs|April 6, 2019
Misleading impaired liver function in a non-small-cell lung cancer patient treated with pembrolizumab: a case reportGiorgia A Osman, Arnaldo Marra, Daniela Iacono, et al.
Exploration of Targeted Anti-Tumor Therapy|March 10, 2025
Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency dataFabrizio Nelli, Enzo Maria Ruggeri, Antonella Virtuoso, et al.
Scientifica|March 7, 2019
Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot StudyMaria Pia Fuggetta, Maria Rita Migliorino, Serena Ricciardi, et al.
Human Mutation|December 19, 2007
Syndromic true hermaphroditism due to an R-spondin1 (RSPO1) homozygous mutationSara Tomaselli, Francesca Megiorni, Carmelilia De Bernardo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2002
TCL1 participates in early embryonic development and is overexpressed in human seminomasMaria Grazia Narducci, Maria Teresa Fiorenza, Sang-Moo Kang, et al.
American Journal of Clinical Oncology|October 24, 2019
Intrapatient Molecular and Histologic Heterogeneity After First-generation or Second-generation TKI Therapy of NSCLC Patients: Potential Clinical Impact on Subsequent third-generation TKI TreatmentDaniela Iacono, Giorgia A Osman, Maria R Migliorino, et al.
Blood|October 6, 2005
Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IVMaria Grazia Narducci, Enrico Scala, Antonella Bresin, et al.
Cancer Research|September 2, 2008
CXCL13 is highly produced by Sézary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokinesMaria Cristina Picchio, Enrico Scala, Debora Pomponi, et al.
World Journal of Hepatology|November 30, 2011
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphomaAdriano M Pellicelli, Massimo Marignani, Valerio Zoli, et al.
British Journal of Haematology|November 13, 2023
The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman-like lymphadenopathies: A 20-year retrospective analysis of clinical and pathological featuresSabrina Pelliccia, Evelina Rogges, Antonello Cardoni, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Anti-Cancer Drugs|April 6, 2019
Misleading impaired liver function in a non-small-cell lung cancer patient treated with pembrolizumab: a case reportGiorgia A Osman, Arnaldo Marra, Daniela Iacono, et al.
Exploration of Targeted Anti-Tumor Therapy|March 10, 2025
Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency dataFabrizio Nelli, Enzo Maria Ruggeri, Antonella Virtuoso, et al.
Scientifica|March 7, 2019
Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot StudyMaria Pia Fuggetta, Maria Rita Migliorino, Serena Ricciardi, et al.
Human Mutation|December 19, 2007
Syndromic true hermaphroditism due to an R-spondin1 (RSPO1) homozygous mutationSara Tomaselli, Francesca Megiorni, Carmelilia De Bernardo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2002
TCL1 participates in early embryonic development and is overexpressed in human seminomasMaria Grazia Narducci, Maria Teresa Fiorenza, Sang-Moo Kang, et al.
American Journal of Clinical Oncology|October 24, 2019
Intrapatient Molecular and Histologic Heterogeneity After First-generation or Second-generation TKI Therapy of NSCLC Patients: Potential Clinical Impact on Subsequent third-generation TKI TreatmentDaniela Iacono, Giorgia A Osman, Maria R Migliorino, et al.
Blood|October 6, 2005
Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IVMaria Grazia Narducci, Enrico Scala, Antonella Bresin, et al.
Cancer Research|September 2, 2008
CXCL13 is highly produced by Sézary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokinesMaria Cristina Picchio, Enrico Scala, Debora Pomponi, et al.
World Journal of Hepatology|November 30, 2011
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphomaAdriano M Pellicelli, Massimo Marignani, Valerio Zoli, et al.
British Journal of Haematology|November 13, 2023
The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman-like lymphadenopathies: A 20-year retrospective analysis of clinical and pathological featuresSabrina Pelliccia, Evelina Rogges, Antonello Cardoni, et al.
Pageof 3